The Murlentamab Biosimilar Anti-AMHR2 Antibody is a cutting-edge research tool designed for studying AMHR2, a key protein involved in cell signaling pathways related to cancer development and progression. This antibody, produced using advanced biotechnology techniques, specifically targets AMHR2 in human samples and is validated for use in various experimental applications.AMHR2, also known as anti-Müllerian hormone receptor type II, is a critical player in regulating cell growth, proliferation, and differentiation, particularly in cancer cells. By targeting AMHR2, researchers can gain valuable insights into the mechanisms underlying tumorigenesis and potentially identify new therapeutic targets for cancer treatment.
The Murlentamab Biosimilar Anti-AMHR2 Antibody enables precise detection and analysis of AMHR2 expression in cancer cells, making it an invaluable tool for studies in oncology and molecular biology. Its high specificity and sensitivity ensure reliable and reproducible results, contributing to the advancement of knowledge in cancer research and the development of innovative anti-cancer therapies.
Product Name:
Murlentamab (Anti-AMHR2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0092
Target:
AMHR2
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
3C23K, GM102
Description:
Anti-AMHR2(murlentamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
